31-Valent Pneumococcal Conjugate Vaccine (Vaxcyte)

N/A

Report date: 2026/03/16 20:01:47

Base Information

Drug Name31-Valent Pneumococcal Conjugate Vaccine (Vaxcyte)

Drug Alias Name31-valent PCVPneumonococcal conjugate vaccineVAX31VAX-31

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Bacterial vaccineVaccines > Vaccine type > Multivalent vaccine +[4]

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsPneumococcal Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesPuerto Rico

CombinationsNo

Global Highest StatusPhase 3 Clinical

Highest Status in ChinaN/A

Originator CompaniesVaxcyte Inc

China Registration ClassN/A

Develop Information

Active CompaniesVaxcyte Inc

Inactive CompaniesN/A

Active IndicationsPneumococcal Infections

Inactive IndicationsN/A

Other Information

ATC CodeN/A